FDA
-
-
-
-
-
-
-
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
-
-
-
-
-
-
-
Lisata Therapeutics (LSTA) Granted FDA Rare Pediatric Disease Designation for LSTA1
-
-
-
-
-
-
-
Lisata Therapeutics (LSTA) Granted FDA Orphan Drug Designation Granted to LSTA1
-
-
-
-
322,094 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

